Table 3.
Analysis of risk factors for interstitial pneumonia
| Univariate logistic analysis | Multivariate Cox analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95%CI | P | OR | 95%CI | P | |
| Advanced stage | 2.287 | 1.205–4.340 | 0.011 | |||
| B symptom | 3.278 | 1.651–6.510 | 0.001 | 4.221 | 1.852–9.622 | 0.001 |
| Lung involvement | 1.320 | 0.468–3.730 | 0.600 | |||
| History of drug allergy | 2.797 | 1.092–7.159 | 0.032 | 4.019 | 1.375–11.750 | 0.011 |
| History of cigarette smoking | 0.407 | 0.192–0.864 | 0.019 | |||
| ECOG > 1 | 1.613 | 0.940–2.768 | 0.083 | |||
| Extranodal involvement | 1.741 | 0.869–3.490 | 0.118 | |||
| Rituximab | 1.589 | 0.844–2.989 | 0.151 | |||
| Bleomycin | 1.000 | 0.335–2.989 | 1.000 | |||
| ALC < 1 × 109/L | 1.439 | 0.678–3.053 | 0.343 | |||
ALC, absolute lymphocyte count; CI, confidence interval; ECOG, Eastern Cooperative Oncology Group; OR, odds ratio